Daniel J. O'Connor - 20 Feb 2025 Form 3 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Director
Signature
/s/ Amy E. Culbert, attorney-in-fact
Issuer symbol
DMAC
Transactions as of
20 Feb 2025
Net transactions value
$0
Form type
3
Filing time
24 Feb 2025, 16:54:22 UTC
Previous filing
07 Mar 2024

No securities are beneficially owned.